Mitchell L. Leibowitz
Impact in
- Aging top 10%
Papers in
- Genetics 3
- Virus-based gene therapy research 2
- Genomic variations and chromosomal abnormalities 1
-
- CRISPR and Genetic Engineering 3
- Pluripotent Stem Cells Research 2
- Retinal Development and Disorders 2
- Co-authors
- Cheng-Zhong Zhang (3 shared papers)David S. Pellman (3 shared papers)Stamatis Papathanasiou (2 shared papers)Mitchell J. Weiss (1 shared paper)Lili Sun (1 shared paper)Phillip A. Doerfler (1 shared paper)Yu Yao (1 shared paper)Jae Ho Lee (1 shared paper)
- Journals
- Annual Review of Genetics (1 paper)Experimental & Molecular Medicine (1 paper)Cell stem cell (1 paper)Nature Communications (1 paper)Nature Genetics (1 paper)
- Partner nations
- United StatesSouth KoreaCanada
In The Last Decade
Mitchell L. Leibowitz
6 papers receiving 849 citations
Mitchell L. Leibowitz's Hit Papers
Peers
Comparison fields: 5 of 73
- Business and International Management 41
- Aging 28
- Molecular Biology 704
- Genetics 205
- Cancer Research 95
Countries citing papers authored by Mitchell L. Leibowitz
This map shows the geographic impact of Mitchell L. Leibowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell L. Leibowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell L. Leibowitz more than expected).
Fields of papers citing papers by Mitchell L. Leibowitz
This network shows the impact of papers produced by Mitchell L. Leibowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell L. Leibowitz. The network helps show where Mitchell L. Leibowitz may publish in the future.
Co-authors
The 19 scholars most cited alongside Mitchell L. Leibowitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Chromothripsis as an on-target consequence of CRISPR–Cas9 genome editing Hit paper breakdown → | 2021 | 426 |
| 2 | 2015 | 160 | |
| 3 | 2020 | 98 | |
| 4 | 2011 | 93 | |
| 5 | 2021 | 88 | |
| 6 | 2024 | 7 |
About Mitchell L. Leibowitz
Mitchell L. Leibowitz is a scholar working on Genetics, Molecular Biology, Cancer Research, Plant Science and Immunology, having authored 6 papers that have together received 872 indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (3 papers), Pluripotent Stem Cells Research (2 papers), Chromosomal and Genetic Variations (2 papers), Virus-based gene therapy research (2 papers), Retinal Development and Disorders (2 papers), Cancer Genomics and Diagnostics (1 paper), Genomic variations and chromosomal abnormalities (1 paper) and interferon and immune responses (1 paper). The work is most often cited by research in Business and International Management (41 citations), Aging (28 citations), Molecular Biology (704 citations), Genetics (205 citations) and Cancer Research (95 citations). Mitchell L. Leibowitz has collaborated with scholars based in United States, South Korea and Canada. Frequent co-authors include Cheng-Zhong Zhang, David S. Pellman, Stamatis Papathanasiou, Mitchell J. Weiss, Lili Sun, Phillip A. Doerfler, Yu Yao, Jae Ho Lee, Mijung Kwon and Aaron R. Quinlan. Their work appears in journals such as Annual Review of Genetics, Experimental & Molecular Medicine, Cell stem cell, Nature Communications and Nature Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.